Related Experiment Videos
Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acid is based on different mechanisms
1Department of Pediatric Surgery, Klinikum Schmarrenberg, University of Tübingen, Germany.
Abstract:
Hydroxymethyl-glutaryl-CoA-reductase (HMG-CoA-reductase), the key enzyme for cholesterol synthesis and essential for the synthesis of the precursor for p21ras farnesylation, was inhibited in neuroblastoma cells by lovastatin or L-ascorbic acid. Both compounds inhibited clonogenic colony formation of neuroblastoma cells in soft agar. However, while the addition of mevalonate, the product of HMG-CoA-reductase, circumvented the inhibition by lovastatin it had no reversing effect on the inhibition by L-ascorbic acid. The role of reactive oxygen compounds generated by the degradation of catecholamines, and the pro-oxidative effects of L-ascorbic acid are discussed as mechanisms of action of L-ascorbic acid.
Insights
Lovastatin and L-ascorbic acid inhibit neuroblastoma cell growth by targeting HMG-CoA-reductase. Unlike lovastatin, L-ascorbic acid
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Hydroxymethyl-glutaryl-CoA-reductase (HMG-CoA-reductase) is crucial for cholesterol synthesis and p21ras farnesylation.
- Neuroblastoma is a pediatric cancer with a need for effective therapeutic targets.
Purpose of the Study:
- To investigate the inhibitory effects of lovastatin and L-ascorbic acid on neuroblastoma cells.
- To elucidate the mechanism of action of these compounds.
Main Methods:
- Inhibition of HMG-CoA-reductase in neuroblastoma cells using lovastatin and L-ascorbic acid.
- Assessing clonogenic colony formation in soft agar.
- Investigating the effect of mevalonate addition.
Main Results:
- Both lovastatin and L-ascorbic acid inhibited neuroblastoma cell colony formation.
- Mevalonate reversed lovastatin's inhibition but not L-ascorbic acid's.
- L-ascorbic acid's mechanism may involve reactive oxygen species.
Conclusions:
- HMG-CoA-reductase inhibition is a viable strategy against neuroblastoma.
- L-ascorbic acid exhibits anti-neuroblastoma activity through a distinct mechanism potentially involving oxidative stress.